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ailure of cells to cleave at the end of mitosis is danger-
ous to the organism because it immediately produces
tetraploidy and centrosome ampliﬁcation, which is
thought to produce genetic imbalances. Using normal human
and rat cells, we reexamined the basis for the attractive and
increasingly accepted proposal that normal mammalian
cells have a “tetraploidy checkpoint” that arrests binucleate
cells in G1, thereby preventing their propagation. Using 10
 
 
 
M cytochalasin to block cleavage, we conﬁrm that most
F
 
binucleate cells arrest in G1. However, when we use lower
concentrations of cytochalasin, we ﬁnd that binucleate
cells undergo DNA synthesis and later proceed through
mitosis in 
 
 
 
80% of the cases for the hTERT-RPE1 human
cell line, primary human ﬁbroblasts, and the REF52 cell
line. These observations provide a functional demonstration
that the tetraploidy checkpoint does not exist in normal
mammalian somatic cells.
 
Introduction
 
The purpose of mitosis is the division of a cell into two
genetically identical daughters. However, a number of mitotic
defects can abrogate the essential fidelity of the process. Some,
such as naturally occurring chromosome monoorientation,
can be remediated through the action of a checkpoint that
stops mitotic progression until all kinetochores are attached
to the spindle. Other defects, such as cleavage failure, are
intractable. Cleavage failure can arise from a defective ac-
tomyosin cleavage apparatus, defects in the abscission of
the midbody, chromosome bridging, merotelically attached
chromosomes lodged in the cleavage furrow, and spindle
malorientation (for review see Margolis et al., 2003; Storchova
and Pellman, 2004). For mammalian somatic cells, cleavage
failure is normally a rare event in culture (Piel et al., 2001)
and is assumed to be a rare event in vivo
 
.
 
 Nevertheless, if
and when cleavage failure does occur, it is thought to be
particularly dangerous to the organism because both the
chromosome complement and centrosome number are
doubled. Extra centrosomes greatly increase the chances that
the subsequent mitosis will be multipolar and chromosomes
will be unequally distributed to multiple daughter cells (for
review see Brinkley, 2001; Nigg, 2002; Sluder and Nordberg,
2004). In addition, the extra complement of chromosomes
increases the chances that some of the aneuploid daugh-
ter cells will have enough genetic information to be via-
ble. Cleavage failure is acknowledged to be a significant (if
not primary) source of centrosome amplification (Brinkley,
2001; Borel et al., 2002; Meraldi et al., 2002). Genomic
instability brought on by unequal chromosome distribution
is thought to be a major driving force in multi-step carcino-
genesis (for review see Nigg, 2002; Sluder and Nordberg,
2004). Indeed, tetraploidization often precedes aneuploidy
in solid tumors (for review see Nigg, 2002).
Given the perceived dangers of cleavage failure, it has been
of interest to determine if there are mechanisms that block
the proliferation of cells that fail cleavage and become tetra-
ploid. The notion that cells have a p53-dependent check-
point that blocks the propagation of cells that failed to divide
originated with findings that continuous treatment of normal
cells with cytochalasin to block cleavage leads to a cell cycle
arrest (Carter, 1967; Wright and Hayflick, 1972; Hirano
and Kurimura, 1974; Lohez et al., 2003). In addition, cells
treated with microtubule inhibitors eventually adapt to spindle
assembly checkpoint, exit mitosis without dividing, and
arrest in G1 (Minn et al., 1996; Lanni and Jacks, 1998).
Similar experiments on cells with a compromised p53 path-
way revealed that they continue cycling (Minn et al., 1996;
Lanni and Jacks, 1998; Andreassen et al., 2001). The most
clear and most explicit demonstration of this checkpoint
came from a report by Andreassen et al. (2001) that used
dihydrocytochalasin B to inhibit cytokinesis in REF52 cells,
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a primary rat fibroblast cell line. After drug removal, they
found that the tetraploid cells arrested in G1, whereas many
of the mononucleate cells in the same preparations contin-
ued cycling. By temporally separating the G1 arrest from the
action of the drug, these workers provided evidence that the
arrest was specific to the binucleate condition. Further indi-
cations that this arrest was due to failed cleavage came from
observations that expression of a dominant-negative mutant
p53 allowed the binucleates to undergo DNA synthesis.
The notion that normal mammalian somatic cells have a
“tetraploidy checkpoint” that arrests binucleate cells in G1
after cleavage failure has been intensely attractive for many,
including ourselves, because it provides a logical way for an
organism to deal with a potentially dangerous and intracta-
ble situation (for review see Margolis et al., 2003). Not
surprisingly, this proposed checkpoint has received con-
siderable interest and has been reviewed as an established
mechanism. However, the universal applicability of this
checkpoint is brought into question by evidence that liver
regrowth in living humans and rodents is due in part to the
proliferation of multinucleate hepatocytes (for review see
Fausto and Campbell, 2003).
Our interest in this checkpoint led us to initiate a series of
experiments with telomerase-immortalized normal human
cells (hTERT-RPE1) to determine what event or condition
this checkpoint monitors. Using cytochalasin D at the
concentration used by Andreassen et al. (2001) for dihy-
drocytochalasin B, we essentially reproduced their results.
However, our finding that a significant percentage of the bi-
nucleates synthesized DNA prompted us to reexamine the
link between cleavage failure and G1 arrest using lower drug
concentrations and modification of substrate characteristics.
 
Results and discussion
 
hTERT-RPE1 cells
 
Asynchronous hTERT-RPE1 cells were treated with 10 
 
 
 
M
cytochalasin D for 12 h, washed five times with fresh me-
dium, and then put in medium containing BrdU. This con-
centration of cytochalasin D is same as that was used by An-
dreassen et al. (2001) for dihydrocytochalasin B. After
removal of the drug, approximately half the cells were binu-
cleate. To characterize cell cycle progression, some coverslips
were fixed at 18 h after removal of the drug and assayed for
BrdU incorporation. Other coverslips were mounted on
chambers within 30 min
 
 
 
of drug removal for continuous ob-
servation by time-lapse video microscopy of individual cells
to determine what proportion of the mononucleate and bi-
nucleate cells entered mitosis. We found that 81.8% of
mononucleate cells and 41.3% of binucleate cells incorpo-
rated BrdU (Table I). Time-lapse records revealed that 12 of
20 mononucleate cells went through a normal mitosis,
whereas none of the six binucleate cells entered mitosis
within 72 h of cytochalasin removal (Table I). The same
phenomena were observed for REF52 cells even when we
used a lower dose of cytochalasin to block cleavage (de-
scribed later in the REF52 section). The fact that we can
readily repeat the previous observations indicates that there
is nothing peculiar about our culture conditions or the use
of cytochalasin D that would somehow abrogate the pro-
posed tetraploidy checkpoint.
The fact that 41% of the binucleate cells incorporated
BrdU prompted us to investigate whether the extent of G1
arrest was influenced by the drug dosage. We halved the
concentration of cytochalasin (5 
 
 
 
M) and found that a
higher percentage of the mononucleate cells (93.3%) incor-
porated BrdU and entered mitosis (34/37; Fig. 1 A and Ta-
ble I). Under these conditions, 44.0% of binucleate cells in-
corporated BrdU within 36 h, and none of the 12 followed
initiated mitosis within 72 h.
Our finding that a higher percentage of the mononucle-
ated RPE1 cells incorporated BrdU and entered mitosis at a
lower cytochalasin dose raised the possibility that G1 cell
cycle progression might be influenced by persistent actin
cytoskeletal disruption that could perturb cell interactions
with the substrate. When we cultured these cells on fi-
bronectin-coated coverslips, we observed a dramatically dif-
ferent behavior for the binucleate cells even though the
drug treatment (5 
 
 
 
M) was the same. On this substrate,
93.0% of the mononucleate cells and now 83.0% of the bi-
 
Table I. 
 
Summary of results
Cell type Cytochalasin D Fibronectin BrdU incorporation at
indicated time
Mitosis observed within
indicated time
Mononucleate Binucleate Time Mononucleate Binucleate Time
 
 
 
M% % h h
 
hTERT-RPE1 10
 
 
 
81.8 (
 
n
 
 
 
 
 
 677) 41.3 (
 
n
 
 
 
 
 
 717) @18 12/20 0/6 72
hTERT-RPE1 5
 
 
 
93.3 (
 
n
 
 
 
 
 
 986) 44.0 (
 
n
 
 
 
 
 
 851) @18 34/37 0/12 72
hTERT-RPE1 5
 
 
 
93.0 (
 
n
 
 
 
 
 
 888) 83.0 (
 
n
 
 
 
 
 
 817) @18 31/32 23/32 36
hTERT-RPE1 0.5
 
 
 
92.0 (
 
n
 
 
 
 
 
 818) 77.0 (
 
n
 
 
 
 
 
 861) @18 40/41 13/14 36
hTERT-RPE1 100 (Blebbistatin)
 
 
 
ND ND - 30/32 20/20 18
REF52 0.5
 
 
 
84.7 (
 
n
 
 
 
 
 
 819) 25.0 (
 
n
 
 
 
 
 
 996) @24 8/11 0/6 72
REF52 0.5
 
 
 
93.0 (
 
n
 
 
 
 
 
 887) 85.3 (
 
n
 
 
 
 
 
 874) @24 23/25 12/13 48
Human primary fibroblast 0.5
 
 
 
92.7 (
 
n
 
 
 
 
 
 921) 94.3 (
 
n
 
 
 
 
 
 788) @12 20/23 25/33 36
Human primary fibroblast 0.5
 
 
 
93.2 (
 
n
 
 
 
 
 
 207) 97.5 (
 
n
 
 
 
 
 
 200) @12 24/27 13/13 14
BrdU incorporation: the percentage of mononucleate and binucleate cells that incorporated BrdU are averages of at least three separate experiments;
“
 
n
 
” denotes the total number of cells counted. The times indicate when the coverslips were fixed after removal of cytochalasin or blebbistatin. ND, not
determined. Mitosis: the number of mononucleate and binucleate cells entering mitosis within the duration of the cine records (hours after the removal of
cytochalasin or blebbistatin). The number of cells entering mitosis is shown over the total number of cells followed by continuous time-lapse microscopy. 
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nucleate cells incorporated BrdU (Fig. 1 B and Table I). 23
out of 32 binucleate cells followed went through mitosis
within 36 h. Two showed tripolar divisions, and the re-
mainder divided in a bipolar fashion despite the presence of
four centrosomes.
We note that for 20 of the binucleate cells of this last
dataset, we initiated time-lapse observations of individual
mitotic cells just after addition of the cytochalasin at the
start of the experiments. After 12 h, the cells under observa-
tion were circled on the coverslip with a diamond scribe and
the drug was washed out before time-lapse observations re-
sumed. We found that none of the 20 cells showed any signs
of cleavage furrow formation (Video 1, available at http://
www.jcb.org/cgi/content/full/jcb.200403014/DC1), yet 13
of these binucleates proceeded into mitosis. These observa-
tions indicate that the tetraploidy checkpoint does not mon-
itor the formation of a cleavage furrow.
Next, we lowered the concentration of cytochalasin D to
0.5 
 
 
 
M, the minimum concentration able to inhibit cytoki-
nesis in this cell line, and grew the cells on bare glass. Obser-
vations of cells undergoing mitosis in the presence of this
lower drug concentration revealed that cleavage furrows often
formed, but later regressed (Video 1). We found that 92.0%
of mononucleate cells and 77.0% of binucleated cells incor-
porated BrdU at 18 h (Fig. 1 C and Table I). Time-lapse
video analysis revealed that 40 of 41 mononucleate cells pro-
ceeded through normal mitosis within 36 h, as expected.
Strikingly, 13 of 14 binucleate cells completed mitosis to
form two daughter cells within this period (Fig. 1 D and
Video 2, available at http://www.jcb.org/cgi/content/full/
jcb.200403014/DC1). We note that a higher proportion of
binucleates entered mitosis (13/14) by 36 h than incorpo-
rated BrdU (77%) at 18 h after cytochalasin removal. We
think that this is due to some binucleates being slow to come
Figure 1. hTERT-RPE1 cells. (A–C) Overlaid phase and fluorescence images showing BrdU incorporation in mononucleate and binucleate cells. 
(A) Cells previously treated with 5  M cytochalasin D and cultured on bare glass. Some binucleates have incorporated BrdU and others have not. 
(B) Cells previously treated with 5  M cytochalasin D and cultured on fibronectin-coated glass. Binucleates have incorporated BrdU. 
(C) Cells previously treated with 0.5  M cytochalasin D and cultured on bare glass. Both mononucleate and binucleate cells have incorporated 
BrdU. (D) Cells previously treated with 0.5  M cytochalasin D to block cleavage and cultured on bare glass (images taken from Video 2, 
available at http://www.jcb.org/cgi/content/full/jcb.200403014/DC1). Frames from a time-lapse video sequence showing a binucleate cell 
entering and progressing through mitosis. This cell divides into two despite the presence of four centrosomes. (E) Cells previously treated with 
blebbistatin and cultured on bare glass (images taken from Video 3). Frames from a video sequence showing a binucleate cell entering and 
progressing through mitosis. Phase-contrast microscopy. Times are in h:min after drug removal. Bars, 50  m. 
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into S phase and thus not being counted as BrdU positive by
the time the coverslips were fixed. The time-lapse records
were run twice as long, and this extra time presumably al-
lowed the slower binucleates to go through S phase and enter
mitosis by the time the cine records were terminated. For
BrdU incorporation assays, coverslips were fixed at 18 h be-
cause thereafter the fastest cycling binucleates undergo mito-
sis to form mononucleate cells. Together, these results indi-
cate that the ability of binucleate cells to progress through
interphase is influenced by the concentration of cytochalasin
used to block cleavage, and progression through G1 is not
dependent on the presence of fibronectin on the substrate.
 
Inhibition of cleavage by blebbistatin
 
As an alternative agent to block cleavage, we used the myo-
sin II inhibitor (
 
 
 
)-blebbistatin (Straight et al., 2003).
Asynchronous RPE1 cells, grown on bare glass, were treated
with 100 
 
 
 
M (
 
 
 
)-blebbistatin and individual mitotic cells
were observed by time-lapse cinematography for the 45-min
duration of the treatment. After each cell was circled on the
coverslip with a diamond scribe, the drug was washed out
and time-lapse observations were resumed. None of the cells
exiting mitosis in the presence of the drug showed any fur-
rowing activity (Video 1). Nevertheless, all 20 binucleates
followed went through mitosis by 18 h after drug removal
(Fig. 1 E and Video 3, available at http://www.jcb.org/cgi/
content/full/jcb.200403014/DC1). These results indicate
that the previously observed progression of binucleate RPE1
cells through G1 was not due to unexpected side effects of
cytochalasin that could putatively abrogate the tetraploidy
checkpoint.
 
REF52 cells
 
Next, we wanted to address the theoretical concern that the
hTERT-RPE1 cell line has a diminished response to cleavage
failure or has somehow acquired properties that could con-
ceivably abrogate the proposed tetraploidy checkpoint. Thus,
we turned to the REF52 cell line originally used by Andreas-
sen et al. (2001). Asynchronous REF52 cells were treated
with 0.5 
 
 
 
M cytochalasin D for 4–12 h and were fixed for
Figure 2. REF52 cells. (A and B) Overlaid phase and fluorescence images showing BrdU incorporation in mononucleate and binucleate cells. 
(A) Cells were previously treated with 0.5  M cytochalasin D and cultured on bare glass. Mononucleate cells have incorporated BrdU, whereas 
the binucleates have not. (B) Cells treated with 0.5  M cytochalasin D and cultured on fibronectin-coated glass. Both the mononucleate and 
binucleate cells have incorporated BrdU. (C) Cells previously treated with 0.5  M cytochalasin D and cultured on fibronectin-coated glass 
(images taken from Video 4, available at http://www.jcb.org/cgi/content/full/jcb.200403014/DC1). Frames from a video sequence of two 
binucleate cells in the same field progressing through mitosis. The first to enter mitosis (top row) divides into two, whereas the second (bottom 
row) divides into three. Phase-contrast microscopy. Times are in h:min after cytochalasin D removal. Bars, 50  m. 
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analysis of BrdU incorporation at 24 h after cytochalasin re-
moval; others were observed by continuous time-lapse mi-
croscopy. When cultured on bare glass, 84.7% of mononu-
cleate cells and 25.0% of binucleate cells incorporated BrdU
(Fig. 2 A and Table I). Time-lapse observations revealed that
8 of 11 mononucleate cells and 0 of 6 binucleate cells went
through mitosis within 72 h. However, our results were quite
different when the cytochalasin-treated cells were grown on
fibronectin-coated glass. 93.0% of the mononucleate cells
and now 85.3% of the binucleate cells incorporated BrdU by
24 h after cytochalasin removal (Fig. 2 B and Table I). Also,
23 of 25 mononucleate cells and all but one (12/13) of the
binucleate cells completed mitosis within 48 h (Fig. 2 C, Ta-
ble I; Video 4, available at http://www.jcb.org/cgi/content/
full/jcb.200403014/DC1). As before, we think that a 48-h
duration of the time-lapse records reveals the interphase pro-
gression of binucleates that were slow to enter S phase and
thus were not counted as BrdU positive. Nine of the binucle-
ates divided into two, and three divided into three daughters.
The finding that almost all binucleate REF52 cells, under
such conditions, enter mitosis indicates that rat cells and
RPE1 cells have an equivalent response to cleavage failure.
 
Human primary fibroblasts
 
To avoid any further concerns about the peculiarities of im-
mortalized cell lines, we turned to presenescent primary hu-
man foreskin fibroblasts that are normal in every respect,
including p53 (Di Leonardo et al., 1994). These cells, ob-
tained at population doubling 22, are competent for a to-
tal of 74 population doublings before the onset of senes-
cence (American Type Culture Collection data sheet
supplied with the cells). Asynchronous cultures (population
doublings 23–50) were treated with 0.5 
 
 
 
M cytochalasin D
for 4–12 h to block cleavage. Some coverslips were fixed at
12 h after cytochalasin removal and other coverslips were
used for time-lapse video microscopy. When grown on bare
glass, 92.7% of mononucleate cells and 94.3% of binucleate
cells incorporated BrdU within 12 h of cytochalasin removal
(Fig. 3 A and Table I). Time-lapse observations revealed that
20 of 23 mononucleate cells and 25 of 33 binucleate cells
entered mitosis within 36 h of cytochalasin removal (Fig. 3
C, Table I; Video 5, available at http://www.jcb.org/cgi/
content/full/jcb.200403014/DC1). 19 binucleates divided
into 2, and the remaining 6 divided into 3 daughters. When
these cells were cultured on fibronectin-coated coverslips,
93.2% of mononucleate cells and 97.5% of binucleate cells
incorporated BrdU within 12 h of cytochalasin removal
(Fig. 3 B and Table I). All 13 binucleates followed went
through mitosis within 14 h (Table I). Six showed bipolar
and seven showed tripolar divisions.
To determine if primary human cells have a transient but
significant tetraploidy checkpoint, we analyzed video records
Figure 3. Primary human fibroblasts. (A and B) Overlaid phase and fluorescence images showing BrdU incorporation in mononucleate and 
binucleate cells. (A) Cells previously treated with 0.5  M cytochalasin D and cultured on bare glass. Binucleate cells incorporate BrdU. 
(B) Cells previously treated with 0.5  M cytochalasin D and cultured on fibronectin-coated glass. Binucleate cells incorporate BrdU. (C) Cells 
previously treated with 0.5  M cytochalasin D and cultured on bare glass (images taken from Video 5, available at http://www.jcb.org/cgi/
content/full/jcb.200403014/DC1). Frames from a video sequence of a binucleate cell progressing through mitosis. Phase-contrast microscopy. 
Times are in h:min after cytochalasin D removal. Bars, 50  m. 
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to compare interphase durations for binucleate and mono-
nucleate cells. We defined interphase for binucleates as the
time from removal of the cytochalasin to nuclear envelope
breakdown because cells, regardless of nuclear number, are
arrested in G1 while exposed to cytochalasin (Hirano and
Kurimura, 1974; Bohmer et al., 1996; Lohez et al., 2003).
For mononucleates, we used the time from nuclear envelope
reformation to nuclear envelope breakdown as the duration
of interphase. For fibroblasts cultured on bare glass, inter-
phase averaged 18.5 h (
 
n
 
 
 
 
 
 18) for the binucleates and 16.6 h
(
 
n
 
 
 
 
 
 10) for the mononucleates. For binucleates cultured on
fibronectin-coated glass, interphase averaged 12.1 h (
 
n
 
 
 
 
 
13). Because almost all cells progress into mitosis, we con-
clude that even a 2-h prolongation of interphase is function-
ally insignificant and cannot represent a realistic mechanism
to prevent the propagation of tetraploid cells.
 
Possible causes for binucleate cells arresting in G1
 
Our results with lowered cytochalasin D concentrations sug-
gest that the G1 arrest in binucleate cells observed by a num-
ber of investigators (Carter, 1967; Wright and Hayflick,
1972; Hirano and Kurimura, 1974; Andreassen et al., 2001;
Lohez et al., 2003), and ourselves for higher drug doses, may
be due to subtle disorganization of the actin cytoskeleton
that persists even when the drug is washed out. Such disor-
ganization may induce the p38 and the SAPK/JNK stress-
activated protein kinase pathways (Ailenberg and Silverman,
2003). The observation that the G1 progression of mononu-
cleate cells is seemingly less sensitive than that of binucleate
cells to higher doses of cytochalasin is a possibly informative
phenomenon for which we do not have a definitive explana-
tion. Whatever the difference may be, it must be subtle be-
cause immunofluorescence did not reveal any obvious differ-
ences in F-actin distribution between mononucleate and
binucleate cells (unpublished data). Also, vinculin and phos-
photyrosine immunofluorescence did not reveal any obvious
differences in the number per unit area, size, or distribution
of focal adhesions between mononucleate and binucleate
cells (unpublished data).
 
Summary
 
Our results provide a functional demonstration that normal
human somatic cells and rat cells do not possess a tetraploidy
checkpoint that arrests the cell cycle in G1 after a mitosis in
which cleavage fails. Thus, cleavage failure is still, in princi-
ple, a potentially dangerous event for the organism. Given
the perceived dangers of cleavage failure, it is interesting that
neoplastic transformation does not occur at a higher rate than
it does during the many mitoses that take place during devel-
opment, growth, and adult life of humans. This suggests that
in the living organism, cleavage failure is either essentially
nonexistent or not sufficient by itself to cause problems.
 
Materials and methods
 
Cells and cell culture
 
Telomerase-immortalized normal human cells (hTERT-RPE1) were ob-
tained from CLONTECH Laboratories and were cultured in 1:1 DME and
Ham’s F12 media (Sigma-Aldrich). REF52 cells (a rat embryo fibroblast
line) were obtained from Dr. Yu-Li Wang (University of Massachusetts,
Worcester, MA) and were cultured in DME (Sigma-Aldrich). Human pri-
mary foreskin fibroblasts (BJ strain) were obtained from American Type
Culture Collection (Manassas, VA) and cultured at 
 
 
 
50 doublings in MEM
(Sigma-Aldrich). All media also contained 12–25 mM Hepes, 10% FCS (In-
vitrogen), 100 U/ml penicillin G, and 100 
 
 
 
g/ml streptomycin (Invitrogen).
Time-lapse video analysis revealed that cell doubling times were 14–24 h
for hTERT-RPE1 cells, 19–27 h for REF52 cells, and 16–21 h for human pri-
mary fibroblasts. Cytochalasin D (Sigma-Aldrich) and (
 
 
 
)-blebbistatin (Tor-
onto Research Chemicals, Inc.) were used at the indicated concentrations
by dilution of DMSO stocks. To terminate drug treatments, cells were
washed with drug-free medium more than five times over a period of 30
min. 1 ml of 20 
 
 
 
g/ml fibronectin solution (F1141; Sigma-Aldrich) was ap-
plied for 30 min at 37
 
 
 
C to cleaned 22 
 
 
 
 22-mm coverslips previously
treated with poly-
 
L
 
-lysine.
 
BrdU incorporation
 
After cytochalasin D removal, BrdU (Sigma-Aldrich) was added to a final
concentration of 5 
 
 
 
g/ml. After fixation in 
 
 
 
20
 
 
 
C methanol, the cells were
treated with 2N HCL at 22
 
 
 
C for 30 min, incubated with 1:500 mouse anti-
BrdU antibody (Becton Dickinson), and labeled with 1:1,000 goat FITC-
mouse antibody (Molecular Probes, Inc.). Observations were made with a
microscope (DMR series; Leica) equipped for phase contrast and fluores-
cence. Images were recorded with a camera (Retiga 1300; Qimaging
Corp.) and with QCapture software (Qimaging Corp.).
 
Time-lapse video analysis
 
Coverslips bearing cells were assembled into chambers (Hinchcliffe et al.,
2001) containing cytochalasin D or (
 
 
 
)-blebbistatin at the indicated con-
centrations. Individual binucleate cells were circled on the coverslip with
a diamond scribe and then followed at 37
 
 
 
C with Universal (Carl Zeiss Mi-
croImaging, Inc.) or BH-2 (Olympus) microscopes equipped with phase-
contrast or differential interference contrast optics. After 4 h cytochalasin
D or 45 min (
 
 
 
)-blebbistatin exposure, the coverslips were washed with
medium and time-lapse recordings were resumed. Some time-lapse obser-
vations began just after removal of the cytochalasin D. Images were re-
corded with Orca ER, Orca 100 (Hamamatsu Corporation), and Retiga EX
or EXi (Qimaging Corp.) cameras; sequences were written to the hard
drives of PC computers using C-imaging software (Compix, Inc.) or Slide-
Book software (Intelligent Imaging Innovations) and were exported as
QuickTime movies.
 
Online supplemental material
 
Time-lapse sequences of cells failing cleavage and binucleate cells pro-
gressing through mitosis are available at http://www.jcb.org/cgi/content/
full/jcb.200403014/DC1.
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